Showing 1 - 10 of 21
Oped, Postbag, Published on 08/12/2025
» Re: "Thai bourse seeks to jump start growth", (Business, Dec 6).
News, Peter Singer & Benjamin L Sievers, Published on 13/09/2025
» At the University of California, San Diego (UCSD), a programme called Last Gift offers terminally ill patients the opportunity to help create more effective treatments. Their special circumstances transform the usual risk-benefit calculus of joining a clinical study of an untested drug. Researchers can ask them to consider consenting to being research participants in ways that they would not ask healthier people with long life expectancies, and terminally ill patients may choose to give that consent when others would be less likely to do so.
Oped, Postbag, Published on 09/09/2025
» Re: "Most Thais want parliament dissolved immediately, charter change: poll", (BP, Sept 7).
Postbag, Published on 07/09/2025
» Re: "China's lessons from WWII endure", (Opinion, Sept 2).
Editorial, Published on 10/08/2025
» Imagine the shock of enjoying a mini-pancake snack, only to discover it was wrapped in a paper pouch made from a reused patient record -- one that specified a diagnosis of hepatitis B.
Oped, Muhammad Radzi Abu Hassan, Published on 29/04/2025
» The successful collaboration between the health ministries of Malaysia and Thailand, industry partners in Egypt and Malaysia, and the Drugs for Neglected Diseases initiative (DNDi) to bring a new hepatitis C antiviral drug -- ravidasvir -- to market in 2022 was an important milestone. For years, a 12-week course of treatment using sofosbuvir cost between $70,000 (2.34 million baht) and $80,000, putting it out of reach for many in the Global South. But ravidasvir -- a safe and effective alternative when combined with sofosbuvir -- costs far less, averaging less than $500 per course.
Oped, Glenda Gray, Published on 28/11/2024
» Over the last half-century, the number of children who die before reaching the age of five has fallen dramatically, from around 20 million in 1960 to 4.9 million in 2022, largely owing to the Expanded Programme on Immunisation (EPI). Established by the World Health Organization (WHO) in 1974, the EPI has been extraordinarily successful in providing the youngest people with access to vaccines, saving more than 150 million lives. But while such progress is worthy of celebration, there is still much work to do, because newborns comprise half of all deaths in children under five each year, many of which are caused by infection.
Tatat Bunnag, Published on 04/09/2023
» Those who've been following the news lately will probably have heard that political activist Chuwit Kamolvisit publicly disclosed that he has stage 3 liver cancer and is currently undergoing chemotherapy. He also added that his doctors have given him only eight months to live.
Oped, Poonam Khetrapal, Published on 03/08/2023
» To mark World Hepatitis Day, the World Health Organization (WHO) is urging policymakers, health care providers and political and civil society leaders in the Southeast Asia region and globally to accelerate hepatitis testing and treatment, recognising that everyone, everywhere has just "one life" and "one liver" -- the theme of this year's event.
News, Postbag, Published on 30/06/2022
» Re: "Protect those at risk", (PostBag, June 26).